244 related articles for article (PubMed ID: 20049904)
1. Anti-retroviral activity of TRIM5 alpha.
Nakayama EE; Shioda T
Rev Med Virol; 2010 Mar; 20(2):77-92. PubMed ID: 20049904
[TBL] [Abstract][Full Text] [Related]
2. TRIM5α and Species Tropism of HIV/SIV.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():13. PubMed ID: 22291694
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5 alpha.
Kuroishi A; Bozek K; Shioda T; Nakayama EE
Retrovirology; 2010 Jul; 7():58. PubMed ID: 20609213
[TBL] [Abstract][Full Text] [Related]
4. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
[TBL] [Abstract][Full Text] [Related]
5. Evolution of a TRIM5-CypA splice isoform in old world monkeys.
Newman RM; Hall L; Kirmaier A; Pozzi LA; Pery E; Farzan M; O'Neil SP; Johnson W
PLoS Pathog; 2008 Feb; 4(2):e1000003. PubMed ID: 18389077
[TBL] [Abstract][Full Text] [Related]
6. Independent evolution of an antiviral TRIMCyp in rhesus macaques.
Wilson SJ; Webb BL; Ylinen LM; Verschoor E; Heeney JL; Towers GJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3557-62. PubMed ID: 18287035
[TBL] [Abstract][Full Text] [Related]
7. Impact of TRIM5α in vivo.
Nakayama EE; Shioda T
AIDS; 2015 Sep; 29(14):1733-43. PubMed ID: 26372380
[TBL] [Abstract][Full Text] [Related]
8. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
[TBL] [Abstract][Full Text] [Related]
9. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
Nakayama EE; Miyoshi H; Nagai Y; Shioda T
J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780
[TBL] [Abstract][Full Text] [Related]
10. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
Javanbakht H; Diaz-Griffero F; Stremlau M; Si Z; Sodroski J
J Biol Chem; 2005 Jul; 280(29):26933-40. PubMed ID: 15897199
[TBL] [Abstract][Full Text] [Related]
11. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
12. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.
Kono K; Song H; Yokoyama M; Sato H; Shioda T; Nakayama EE
Retrovirology; 2010 Sep; 7():72. PubMed ID: 20825647
[TBL] [Abstract][Full Text] [Related]
13. Role of Human TRIM5α in Intrinsic Immunity.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():97. PubMed ID: 22435067
[TBL] [Abstract][Full Text] [Related]
14. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.
Lin TY; Emerman M
Virology; 2008 Sep; 379(2):335-41. PubMed ID: 18678385
[TBL] [Abstract][Full Text] [Related]
15. Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
Li X; Song B; Xiang SH; Sodroski J
Virology; 2007 Sep; 366(2):234-44. PubMed ID: 17543365
[TBL] [Abstract][Full Text] [Related]
16. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.
Grütter MG; Luban J
Curr Opin Virol; 2012 Apr; 2(2):142-50. PubMed ID: 22482711
[TBL] [Abstract][Full Text] [Related]
17. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
[TBL] [Abstract][Full Text] [Related]
19. A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue.
Nakayama EE; Maegawa H; Shioda T
Virology; 2006 Jun; 350(1):158-63. PubMed ID: 16647098
[TBL] [Abstract][Full Text] [Related]
20. [TRIM5alpha].
Nakayama EE; Shioda T
Uirusu; 2005 Dec; 55(2):259-65. PubMed ID: 16557011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
